The federal government is taking a new approach to overseeing one of the country's fastest-growing healthcare programs.

Chad Hatfield, Pharm.D., of UC Davis Health, says rebate model readiness starts with a spend review and data that pharmacy ...

Drugmakers want a say in court to defend a rebate pilot in the 340B drug discount program that hospitals are trying to stop.

It’s the second time the HHS has tried to kickstart a 340B rebate program — and the second time hospitals have sued to block ...

In response to news in the 340B Report last week that was highly critical of the drug industry's noncompliance with compulsory elements of the 340B drug pricing program, AIDS Healthcare Foundation ...

Chad Hatfield, Pharm.D., of UC Davis Health, says 340B savings fund free clinics and mental health care that could shrink as ...

A controversial program to subsidize safety-net hospitals’ drug spending “has expanded beyond its original intent,” ...

On behalf of our nearly 5,000 member hospitals, health systems and other healthcare organizations, including more than 2,000 hospitals and health systems that participate in the 340B Drug Pricing ...

As we enter into the final months of 2024, new developments in the administration of the 340B Drug Pricing Program signal that additional reform may be on the way. Although recent revisions to the ...

An HHS report finds the 340B program has strayed from its original intent, favoring hospital profit over patients, as spread ...

The high list prices of gene therapies command the media’s attention and that of policymakers and payers. Late last year, the Food and Drug Administration (FDA) approved the world’s first gene therapy ...